DIGOXIN Drug Patent Profile
✉ Email this page to a colleague
When do Digoxin patents expire, and what generic alternatives are available?
Digoxin is a drug marketed by Amici, Hikma, Vistapharm Llc, Abraxis Pharm, Hospira, Sandoz, West-ward Pharms Int, Wyeth Ayerst, Aurobindo Pharma Ltd, Hikma Intl Pharms, Impax Labs, Novitium Pharma, Rising, Stevens J, and Sun Pharm Inds Inc. and is included in seventeen NDAs.
The generic ingredient in DIGOXIN is digoxin. There are ten drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the digoxin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Digoxin
A generic version of DIGOXIN was approved as digoxin by RISING on December 23rd, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DIGOXIN?
- What are the global sales for DIGOXIN?
- What is Average Wholesale Price for DIGOXIN?
Summary for DIGOXIN
US Patents: | 0 |
Applicants: | 15 |
NDAs: | 17 |
Finished Product Suppliers / Packagers: | 25 |
Raw Ingredient (Bulk) Api Vendors: | 87 |
Clinical Trials: | 225 |
Patent Applications: | 3,828 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for DIGOXIN |
Drug Sales Revenues: | Drug sales revenues for DIGOXIN |
What excipients (inactive ingredients) are in DIGOXIN? | DIGOXIN excipients list |
DailyMed Link: | DIGOXIN at DailyMed |
![DIGOXIN drug patent expirations Drug patent expirations by year for DIGOXIN](/p/graph/s/t/DIGOXIN-patent-expirations.png)
![Drug Prices for DIGOXIN](/p/graph/drug-price/DIGOXIN.png)
![Drug Sales Revenue Trends for DIGOXIN](/p/graph/drug-sales-revenues/DIGOXIN.png)
Recent Clinical Trials for DIGOXIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
State University of New York - Downstate Medical Center | Phase 1/Phase 2 |
Innovent Biologics (Suzhou) Co. Ltd. | Phase 1 |
Boehringer Ingelheim | N/A |
Pharmacology for DIGOXIN
Drug Class | Cardiac Glycoside |
Medical Subject Heading (MeSH) Categories for DIGOXIN
Anatomical Therapeutic Chemical (ATC) Classes for DIGOXIN
US Patents and Regulatory Information for DIGOXIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amici | DIGOXIN | digoxin | ELIXIR;ORAL | 215209-001 | Mar 11, 2022 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Novitium Pharma | DIGOXIN | digoxin | TABLET;ORAL | 215307-001 | Nov 22, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Sun Pharm Inds Inc | DIGOXIN | digoxin | TABLET;ORAL | 076363-001 | Jan 31, 2003 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Sandoz | DIGOXIN | digoxin | INJECTABLE;INJECTION | 040481-001 | Aug 21, 2003 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Abraxis Pharm | DIGOXIN | digoxin | INJECTABLE;INJECTION | 083217-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Aurobindo Pharma Ltd | DIGOXIN | digoxin | TABLET;ORAL | 214982-003 | Feb 8, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Rising | DIGOXIN | digoxin | TABLET;ORAL | 040282-001 | Dec 23, 1999 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |